Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Alter

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 10, 2007
Therapeutic lifestyle and disease-management interventions: pushing the scientific envelopeDavid A Alter
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 17, 2017
The eco-biological-behavioural perfect storm that follows heavy snowfallDavid A Alter
Annals of Internal Medicine|September 12, 2017
Tracking Our Physical Inactivity and Progression to Death: Is This Evolutionary Stagnation?David A Alter
American Heart Journal|December 9, 2003
Are some patients in Canada treated more equally than others? The Orwell prophecyDavid A Alter
Journal of the American College of Cardiology|October 24, 2015
Merits and Pitfalls of Using Observational "Big Data" to Inform Our Understanding of Socioeconomic Outcome DisparitiesDavid A Alter
Journal of the American College of Cardiology|April 29, 2026
From Insight to Infrastructure: Managing Cardiorespiratory FitnessDavid A Alter
Annals of Translational Medicine|January 20, 2023
Pharmacogenetic screening in a knowledge-based economy: shouldn't more be better?David A Alter
ACP Journal Club|November 3, 2007
High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromesDavid A Alter
Circulation. Cardiovascular Quality and Outcomes|October 5, 2017
When Do We Decide That Generic and Brand-Name Drugs Are Clinically Equivalent? Perfecting Decisions With Imperfect EvidenceDavid A Alter
Population Health Management|August 12, 2009
The application of disease management to clinical trial designsJared Puterman, David A Alter
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 10, 2007
Therapeutic lifestyle and disease-management interventions: pushing the scientific envelopeDavid A Alter
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 17, 2017
The eco-biological-behavioural perfect storm that follows heavy snowfallDavid A Alter
Annals of Internal Medicine|September 12, 2017
Tracking Our Physical Inactivity and Progression to Death: Is This Evolutionary Stagnation?David A Alter
American Heart Journal|December 9, 2003
Are some patients in Canada treated more equally than others? The Orwell prophecyDavid A Alter
Journal of the American College of Cardiology|October 24, 2015
Merits and Pitfalls of Using Observational "Big Data" to Inform Our Understanding of Socioeconomic Outcome DisparitiesDavid A Alter
Journal of the American College of Cardiology|April 29, 2026
From Insight to Infrastructure: Managing Cardiorespiratory FitnessDavid A Alter
Annals of Translational Medicine|January 20, 2023
Pharmacogenetic screening in a knowledge-based economy: shouldn't more be better?David A Alter
ACP Journal Club|November 3, 2007
High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromesDavid A Alter
Circulation. Cardiovascular Quality and Outcomes|October 5, 2017
When Do We Decide That Generic and Brand-Name Drugs Are Clinically Equivalent? Perfecting Decisions With Imperfect EvidenceDavid A Alter
Population Health Management|August 12, 2009
The application of disease management to clinical trial designsJared Puterman, David A Alter
Pageof 15